STAT+: Pharmalittle: Some Republicans push to probe Pfizer over Covid-19 ‘mutations’; Warren urges FTC to probe pharma mergers
And so, another working week will soon draw to a close. Not a moment too…
Category: pharmalittle
STAT+: Pharmalittle: Strange bedfellows lobby for Medicare coverage of obesity drugs; FDA working with WHO to probe cough syrups
Hello, everyone, and how are you this morning? We are doing just fine, thank you,…
STAT+: Pharmalittle: Merck ends late-stage trial for Keytruda in prostate cancer; doctor group says 60 Minutes segment on Wegovy was an ad
Good morning, everyone, and how are you today? We are doing just fine, thank you,…
STAT+: Pharmalittle: Amazon adds $5 monthly generic drug subscription; PhRMA ends lobbying contract with brother of White House official
Rise and shine, everyone, another busy day is on the way. We can tell thanks…
.jpg)
STAT+: Pharmalittle: Obesity guidelines cause backlash; Bayer is pushed to spin off its consumer health business
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: Pharmalittle: FDA rejects Lilly application for Alzheimer’s drug; Sanofi offers a warranty for a medicine
And so, another working week will soon draw to a close. Not a moment too…
STAT+: Pharmalittle: India regulator finds 5% of drug samples are substandard; EMA claims new clinical trial registry is fixed
Hello, everyone, and how are you today? A steely gray sky is hovering this morning…
STAT+: Pharmalittle: HIV vaccine study is stopped early; Merck has a plan to combat carcinogen found in diabetes drugs
Top of the morning to you. The middle of the week is upon us and,…
STAT+: Pharmalittle: Lilly and AbbVie exit U.K. drug-pricing program; J&J scales back Covid-19 vaccine production
Good morning, everyone, and welcome to another working week, which is only getting started on…
STAT+: Pharmalittle: Pharma prioritizes biologics over pills due to drug-pricing law; former Takeda employee accused of creating fake consulting firm
And so, another working week will soon draw to a close. Not a moment too…
STAT+: Pharmalittle: HHS readying details for Medicare drug-price negotiations; doctors urge FDA to hold expert meeting before approving Alzheimer’s drug
Top of the morning to you. Gray skies are hovering over the Pharmalot campus right…
STAT+: Pharmalittle: Pfizer will not license generic Covid-19 pill in China; BioMarin signs outcomes-based deal in Germany for gene therapy
Good morning, everyone, and welcome to the middle of the week. Congratulations on making it…
STAT+: Pharmalittle: FDA increasingly pauses trials of experimental meds; FDA commish isn’t surprised by congressional report on Alzheimer’s drug
Rise and shine, another busy day is on the way. We can tell if only…
STAT+: Pharmalittle: Pediatricians recommend obesity drugs for children; as JPM starts, industry execs have a gloomy financing outlook
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: Pharmalittle: Pfizer scaling back early-stage research into rare diseases; BioNTech and U.K. partner on cancer trials
And so, another working week will soon draw to a close. Not a moment too…
STAT+: Pharmalittle: New report gives glimpse into safety of an Alzheimer’s drug; Walgreens looks to dispense an abortion pill
Good morning, everyone, and how are you today? We are doing just fine, thank you,…
STAT+: Pharmalittle: FDA rule change allows pharmacies to offer abortion pills; Medicare could have saved billions if inflationary rebate law existed
Top of the morning to you, and a fine one it is. Balmy breezes and…
STAT+: Pharmalittle: Pharma plans to raise U.S. drug prices in January; U.S. sues AmerisourceBergen over opioid crisis
Good morning, everyone, and welcome to a new year. We hope the holiday respite was…
STAT+: Pharmalittle: FDA approves a Genentech blood-cancer drug; Sean Parker expands his immunotherapy research empire
Good morning, Pharmalittle family! Your loyal scribe Ed Silverman is taking today off, so he…
STAT+: Pharmalittle: Merck pays Chinese biotech $175 million for cancer drugs; who will make a gene therapy for very sick kids?
Good morning everyone! Matthew Herper is here, filling in for Pharmalot, who is taking a…
STAT+: Pharmalittle: ICER cuts cost-effective price for Pfizer Covid pill; McDonald’s sets targets to reduce antibiotic use in cattle
Good morning, everyone, and how are you today? We are doing just fine, thank you,…
STAT+: Pharmalittle: Pharma wins changes in bill concerning accelerated approval; pharmacy chains restrict purchases of pediatric pain relievers
Rise and shine, everyone, another busy day is on the way. And we can tell…
STAT+: Pharmalittle: FDA adds Lilly diabetes drugs to shortage list; WTO delays decision on extending Covid IP waiver
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: Pharmalittle: AbbVie leaves pharma industry trade groups; net drug prices see big drop after inflation
And so, another working week will soon draw to a close. Not a moment too…
.jpg)
STAT+: Pharmalittle: U.S. prisons refuse to test and treat hepatitis C patients; HHS urges Supreme Court to reject Pfizer argument on Medicare kickbacks
Good morning, everyone, and how are you today? We are doing just fine, thank you,…
STAT+: Pharmalittle: Lawmakers accuse Pfizer of ‘pure greed’ over Covid vaccine price hike; Takeda to spend $4 billion on experimental pill
Good morning, everyone, and how are you today? We are doing just fine, thank you….
STAT+: Pharmalittle: Moderna and Merck vaccine lowers risk of skin cancer relapse; Cambodia halts exports of primates used for drug research
Top of the morning to you, and a fine one it is. Crystal clear blue…
STAT+: Pharmalittle: Amgen agrees to pay $27.8 billion for Horizon Therapeutics; Roche pharma head steps down
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: Pharmalittle: Medicare willing to reevaluate coverage of Alzheimer’s drugs; judge tosses shingles-vaccine lawsuits against Merck
And so, another working week will soon draw to a close. Not a moment too…
STAT+: Pharmalittle: Mark Cuban’s drug company goes after employer market; FDA slaps import alert on key Sun Pharma plant
Top of the morning to you, and a fine one it is. The sun is…
STAT+: Pharmalittle: Zantac lawsuits tossed over inadequate scientific evidence; Lilly tightens access to diabetes drug used for weight loss
Good morning, everyone, and how are you today? We are doing just fine, thank you….
STAT+: Pharmalittle: FDA fast tracks OTC version of Narcan; Express Scripts to keep Humira on its formulary but add biosimilars
Hello, everyone, and how are you today? A steely gray sky is hovering this morning…
STAT+: Pharmalittle: J&J drops out of bidding for Horizon; FDA takes a harder line on fast-track approvals
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: Pharmalittle: Private equity moving to buy clinical trials firms; data provider limits media access to drug prices
And so, another working week will soon draw to a close. Not a moment too…
STAT+: Gilead wins a key battle with the CDC over patents for its Truvada HIV pill
Gilead Sciences won a key round in its battle with the U.S. government over allegations…
STAT+: Pharmalittle: Roche Alzheimer’s drug didn’t clear enough amyloid; startup to seek approval of nasal swab version of naloxone
Good morning, Jason Mast here filling in for Ed. There are many types of coffee…
STAT+: Pharmalittle: Detailed data on Alzheimer’s drug hold up to scrutiny; Horizon in takeover talks with three pharma giants
Rise and shine, everyone. The middle of the week is upon us. Have heart, though….
STAT+: Pharmalittle: PhRMA trade group is losing its edge; Eisai CEO tries to silence critics of Alzheimer’s drug
Hello, everyone, and how are you today? Gray skies are hovering over the Pharmalot campus…
STAT+: Pharmalittle: Second clinical trial death may be linked to Eisai-Biogen Alzheimer’s drug; pharma presses the U.K. over ‘out of control’ levy
Good morning, everyone, and welcome to another working week. We hope the weekend respite —…
STAT+: Pharmalittle: FDA approves first gene therapy for hemophilia B; pharma’s reputation slips in U.S.
Happy Thanksgiving Eve from STAT reporter Andrew Joseph, filling in for the day. A note…
STAT+: Pharmalittle: GSK pulls a key blood-cancer drug off the market; Teva picks a new CEO
Good morning, everyone. Damian Garde here filling in for Ed Silverman in the waning days…
STAT+: Pharmalittle: WHO pandemic accord may force pharma to disclose prices; FDA OKs first therapy to delay type 1 diabetes
And so, another working week will soon draw to a close. Not a moment too…
STAT+: Pharmalittle: Big PBM keeps AbbVie’s Humira on formulary; Lilly CEO says fake tweet means there’s more to do on insulin costs
Good morning, everyone, and how are you today? We are doing just fine, thank you,…
STAT+: Pharmalittle: WHO scientist resigns amid shake-up; FDA considers over-the-counter naloxone
Top of the morning to you. The middle of the week is upon us and,…
STAT+: Pharmalittle: Walmart to pay $3.1 billion to settle opioid claims; Indian Covid vaccine underwent troubling approval process
Good morning, everyone, and how are you today? We are doing just fine, thank you,…
STAT+: Pharmalittle: Roche Alzheimer’s drug fails in two studies; Indivior bets on addiction market with deal to buy Opiant
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: Pharmalittle: Biogen hires Viehbacher as its CEO; new dengue vaccine rolled out amid safety concerns
Top of the morning to you, and a fine one it is. Crystal clear blue…
STAT+: Pharmalittle: Biogen mulls new options in its CEO hunt; NIH starts contacting universities about overdue trial results
Rise and shine, everyone, another busy day is on the way. This is especially true…
STAT+: Pharmalittle: Some Lilly workers want transfers due to Indiana abortion law; GSK cancer drug flops in late-stage study
Good morning, everyone, and welcome to another working week. We hope the weekend respite was…
STAT+: Pharmalittle: Europe approves a Sanofi and AstraZeneca RSV shot; CDC updates opioid prescribing guidelines
And so, another working week will soon draw to a close. Not a moment too…